DNTH vs RF
Dianthus Therapeutics Inc. (DNTH) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
RF (RF) common stock.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
RF does not have a complete income-statement cache yet.
DNTH currently screens at market cap $4.40B. RF currently screens at market cap $0.
Not investment advice. Open the DNTH and RF stock pages for the full models.
Not investment advice.